Ruben de Jesus, Pahtia Technologies

Learn more about a start-up working to improve cancer treatment outcomes

Location: Chan Shun Hall, Garber Auditorium

Date and Time: March 11, 11:30 a.m.

Description:
Over the past 10–15 years, targeted therapies for cancer have greatly increased survivability rates of patients in the U.S., Europe and Japan. However, access to the data needed to prescribe targeted therapies varies by country, and without this knowledge, the treatment options are limited for patients. Moreover, existing targeted therapies were created for the cancers that most affect populations of European heritage, and the cancer burden differs across populations. We see this as a data and global health equity problem.

Pahtiā Technologies Inc. is a global health technology data company leveraging next generation sequencing and artificial intelligence to increase access to targeted therapies for cancer in under-researched populations. Our ultimate goal is to enhance health equity around the world in the fight against cancer.

Speaker: Ruben de Jesus